Health Tech
Takeda Bets Up to $1.7 Billion That an AI Drug Discovery Startup Can Beat the Odds
The deal with Iambic Therapeutics targets cancer, digestive and immune diseases, and follows a wave of multibillion-dollar AI biotech partnerships from AstraZeneca,…
